Supramolecular prodrug inspiried by the Rhizoma Coptidis-Fructus Mume herbal pair alleviated inflammatory diseases by inhibiting pyroptosis
Journal of Pharmaceutical Analysis · 2025-02 · 15 (2) · 101056
DOI: 10.1016/j.jpha.2024.101056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2025-02. Verfasst von Wenhui Qian und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Sustained inflammatory responses are closely related to various severe diseases, and inhibiting the excessive activation of inflammasomes and pyroptosis has significant implications for clinical treatment. Natural products have garnered considerable concern for the treatment of inflammation. Huanglian-Wumei decoction (HLWMD) is a classic prescription used for treating inflammatory diseases, but the necessity of their combination and the exact underlying anti-inflammatory mechanism have not yet been elucidated. Inspired by the supramolecular self-assembly strategy and natural drug compatibility theory, we successfully obtained berberine (BBR)-chlorogenic acid (CGA) supramolecular (BCS), which is an herbal pair from HLWMD. Using a series of characterization methods, we confirmed the self-assembly mechanism of BCS. BBR and CGA were self-assembled and stacked into amphiphilic spherical supramolecules in a 2:1 molar ratio, driven by electrostatic interactions, hydrophobic interactions, and π-π stacking; the hydrophilic fragments of CGA were outside, and the hydrophobic fragments of BBR were inside. This stacking pattern significantly improved the anti-inflammatory performance of BCS compared with that of single free molecules. Compared with free molecules, BCS significantly attenuated the release of multiple inflammatory mediators and lipopolysaccharide (LPS)-induced pyroptosis. Its anti-inflammatory mechanism is closely related to the inhibition of intracellular nuclear factor-kappaB (NF-κB) p65 phosphorylation and the noncanonical pyroptosis signalling pathway mediated by caspase-11.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- Department of Pharmacy, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China.
- Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing, 210023, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qian, W., Zhang, B., Gao, M., Wang, Y., Shen, J., Liang, D., Wang, C., Wei, W., Pan, X., Yan, Q., Sun, D., Zhu, D., & Cheng, H. (2025). Supramolecular prodrug inspiried by the Rhizoma Coptidis-Fructus Mume herbal pair alleviated inflammatory diseases by inhibiting pyroptosis. Journal of Pharmaceutical Analysis, 15(2), 101056. https://doi.org/10.1016/j.jpha.2024.101056
Vancouver
Qian W, Zhang B, Gao M, Wang Y, Shen J, Liang D, et al. Supramolecular prodrug inspiried by the Rhizoma Coptidis-Fructus Mume herbal pair alleviated inflammatory diseases by inhibiting pyroptosis. Journal of Pharmaceutical Analysis. 2025;15(2):101056. doi:10.1016/j.jpha.2024.101056
BibTeX
@article{Qian2025,
author = {Qian, Wenhui and Zhang, Bei and Gao, Ming and Wang, Yuting and Shen, Jiachen and Liang, Dongbing and Wang, Chao and Wei, Wei and Pan, Xing and Yan, Qiuying and Sun, Dongdong and Zhu, Dong and Cheng, Haibo},
title = {Supramolecular prodrug inspiried by the Rhizoma Coptidis-Fructus Mume herbal pair alleviated inflammatory diseases by inhibiting pyroptosis},
journal = {Journal of Pharmaceutical Analysis},
year = {2025},
volume = {15},
number = {2},
pages = {101056},
doi = {10.1016/j.jpha.2024.101056}
}
EUVIMED